tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Chimerix Reports 2024 Losses Amid Acquisition News
PremiumCompany AnnouncementsChimerix Reports 2024 Losses Amid Acquisition News
5M ago
Chimerix Hold Rating: Acquisition by Jazz Pharmaceuticals and Uncertain Clinical Prospects Justify Caution
Premium
Ratings
Chimerix Hold Rating: Acquisition by Jazz Pharmaceuticals and Uncertain Clinical Prospects Justify Caution
5M ago
Chimerix reports Q4 EPS (25c), consensus (28c)
Premium
The Fly
Chimerix reports Q4 EPS (25c), consensus (28c)
5M ago
Chimerix downgraded to Hold from Buy at JonesResearch
PremiumThe FlyChimerix downgraded to Hold from Buy at JonesResearch
5M ago
Strategic Acquisition and NDA Submission Boost Chimerix’s Market Potential
Premium
Ratings
Strategic Acquisition and NDA Submission Boost Chimerix’s Market Potential
5M ago
Cautious Outlook on Chimerix Amid Acquisition and Uncertainties in Drug Approval
Premium
Ratings
Cautious Outlook on Chimerix Amid Acquisition and Uncertainties in Drug Approval
5M ago
Chimerix downgraded to Neutral from Outperform at Wedbush
PremiumThe FlyChimerix downgraded to Neutral from Outperform at Wedbush
5M ago
Chimerix Merges with Jazz Pharmaceuticals in $935M Deal
Premium
Company Announcements
Chimerix Merges with Jazz Pharmaceuticals in $935M Deal
5M ago
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
Premium
The Fly
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100